Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its business ...
Get Lehigh Valley news, Allentown news, Bethlehem news, Easton news, Quakertown news, Poconos news and Pennsylvania news from The Morning Call.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results